Serum glial fibrillary acidic protein is a marker of disease severity in 1 frontotemporal lobar degeneration
暂无分享,去创建一个
H. Zetterberg | G. Binetti | B. Borroni | L. Benussi | R. Ghidoni | T. Karikari | Silvia Fostinelli | R. Gasparotti | A. Benussi | E. Premi | S. Gazzina | N. Ashton | Juan Lantero Rodriguez | M. Giunta | J. Simrén | Blennow | Joel Simrén | Marcello Giunta
[1] G. Frisoni,et al. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer’s disease , 2022, Revista brasileira de psiquiatria.
[2] G. Frisoni,et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] Nick C Fox,et al. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study , 2019, NeuroImage: Clinical.
[4] G. Perea,et al. GABAergic‐astrocyte signaling: A refinement of inhibitory brain networks , 2019, Glia.
[5] K. Fliessbach,et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[6] Nick C Fox,et al. Plasma tau is increased in frontotemporal dementia , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[7] G. Binetti,et al. The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort. , 2017, Journal of Alzheimer's disease : JAD.
[8] B. Barres,et al. Reactive Astrocytes: Production, Function, and Therapeutic Potential. , 2017, Immunity.
[9] Murray Grossman,et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.
[10] M. Jorge Cardoso,et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia , 2016, Neurology.
[11] S. Ourselin,et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia , 2016, Annals of clinical and translational neurology.
[12] K. Blennow,et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.
[13] B. Borroni,et al. White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations , 2016, Neurobiology of Aging.
[14] N. Tomita,et al. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration , 2016, Journal of neurochemistry.
[15] Harald Sontheimer,et al. Glia as drivers of abnormal neuronal activity , 2015, Nature Neuroscience.
[16] A. Strafella,et al. TMS and drugs revisited 2014 , 2015, Clinical Neurophysiology.
[17] Henrik Zetterberg,et al. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction , 2015, PloS one.
[18] S. Rossi,et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee , 2015, Clinical Neurophysiology.
[19] Sterling C. Johnson,et al. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies , 2014, Human brain mapping.
[20] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[21] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[22] R. Lodi,et al. Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia , 2010, Movement disorders : official journal of the Movement Disorder Society.
[23] Julie S. Snowden,et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.
[24] J. Rothwell,et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand , 2000, The Journal of physiology.
[25] L. Rosengren,et al. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple‐system atrophy compared with Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[26] J. Rothwell,et al. Interaction between intracortical inhibition and facilitation in human motor cortex. , 1996, The Journal of physiology.
[27] C. Marsden,et al. Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.
[28] M. Hallett,et al. Human motor evoked responses to paired transcranial magnetic stimuli. , 1992, Electroencephalography and clinical neurophysiology.
[29] K. Chiappa,et al. Magnetic stimulation , 1991, Neurology.
[30] P. Lewczuk,et al. Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment. , 2019, Journal of Alzheimer's disease : JAD.
[31] B. Borroni,et al. Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum. , 2016, Journal of Alzheimer's disease : JAD.
[32] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.